Track IGM Biosciences, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

IGM Biosciences, Inc. IGMS · Stock Open IGM Biosciences, Inc. in new tab

1.27 USD
Add to portfolio
EPS
-0.90
P/B
0.76
ROE
-47.82
Beta
0.59
Target Price
1.12 USD
1M 6M YTD 1Y 2Y 5Y Max
Loading chart...
Key Metrics
EPS-0.90
Book Value1.68
Price to Book0.76
Debt/Equity6298.14
% Insiders35.392%
Growth
Revenue Growth113.53%
Estimates
Forward P/E-0.53
Forward EPS-2.40
Target Mean Price1.12

DCF Valuation

Tweak assumptions to recompute fair value for IGM Biosciences, Inc. (IGMS)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result
Fair Value (DCF)
—
Current Price
—
Upside
—
WACC
—
Terminal PV
—
Σ PV of FCFs
—
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

IGM Biosciences, Inc. Logo IGM Biosciences, Inc. Analysis (IGMS)

United States Health Care Official Website Stock

Is IGM Biosciences, Inc. a good investment? IGM Biosciences, Inc. (IGMS) is currently trading at 1.27 USD. Market analysts have a consensus price target of 1.12 USD. This suggests the asset is currently trading above analyst expectations.

Investor FAQ

Does IGM Biosciences, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is IGM Biosciences, Inc.?

IGM Biosciences, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

Company Profile

IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M antibodies for the treatment of cancer and autoimmune and inflammatory diseases. The company was formerly known as Palingen, Inc. and changed its name to IGM Biosciences, Inc. in 2010. IGM Biosciences, Inc. was incorporated in 1993 and is headquartered in Mountain View, California. As of August 14, 2025, IGM Biosciences, Inc. operates as a subsidiary of Concentra Biosciences, LLC.

Exchange Ticker
NMS (United States) IGMS
Trades
No dividend information available for this instrument.
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion